MIM
AMAG

MetLife Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

MetLife Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,034
Closed -$151K – 2341
2020
Q3 		$151K Hold
16,034
– – ﹤0.01% 2023
2020
Q2 		$123K Hold
16,034
– – ﹤0.01% 2154
2020
Q1 		$99.1K Hold
16,034
– – ﹤0.01% 2083
2019
Q4 		$195K Hold
16,034
– – ﹤0.01% 1987
2019
Q3 		$185K Hold
16,034
– – ﹤0.01% 1996
2019
Q2 		$160K Hold
16,034
– – ﹤0.01% 2158
2019
Q1 		$207K Hold
16,034
– – ﹤0.01% 1967
2018
Q4 		$244K Hold
16,034
– – ﹤0.01% 1801
2018
Q3 		$321K Hold
16,034
– – ﹤0.01% 1812
2018
Q2 		$313K Hold
16,034
– – ﹤0.01% 1698
2018
Q1 		$323K Hold
16,034
– – ﹤0.01% 1638
2017
Q4 		$212K Buy
+16,034
New +$242K ﹤0.01% 1902

MetLife Investment Management's AMAG Position: Q4 2020 in Review

MetLife Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 16,034 shares — an estimated $151K sold.

MetLife Investment Management first reported a position in AMAG in Q4 2017 and held it in 12 quarters. The position peaked at $323K in Q1 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • MetLife Investment Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • MetLife Investment Management sold 16,034 AMAG Pharmaceuticals shares in Q4 2020, an estimated $151K.
  • MetLife Investment Management first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 12 quarters.
  • MetLife Investment Management's AMAG Pharmaceuticals position peaked at $323K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.